| 【英語タイトル】Global High Pressure Contrast Media Injectors Market Size study & Forecast, by Type (Single head injectors, Dual head injectors, Syringeless injectors), By Product (Injector Systems, Consumables), By Application (Interventional cardiology, Interventional radiology, Endovascular surgery, Interventional neuroradiology), By End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23MA210
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年4月1日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、
・産業分野：バイオ
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社発行の本調査レポートによると、2021年に134.1百万ドルであった世界の高圧造影剤インジェクター市場規模が、予測期間中（2022年-2029年）に12.10%以上成長すると予想されます。本レポートは、高圧造影剤インジェクターの世界市場を調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別（シングルヘッド、デュアルヘッド、シリンジレス）分析、製品別（インジェクターシステム、消耗品）分析、用途別（心臓インターベンション、放射線インターベンション、血管内手術、神経放射線インターベンション）分析、エンドユーザー別（病院、診断センター、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、その他）分析、競争分析、調査プロセスなどの内容を掲載しています。なお、参入企業情報として、Guerbet SA、Bracco S.P.A、Bayer AG、Medtron AG、NemotoKyorindo Co., Ltd.、Ulrich GmbH & Co. KG、Sino Medical-Device Technology Co. Ltd.、General electric Company、VIVID Imaging、Apollo RT Co. Ltd.などが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の高圧造影剤インジェクター市場規模：種類別
- シングルヘッドインジェクターの市場規模
- デュアルヘッドインジェクターの市場規模
- シリンジレスインジェクターの市場規模
・世界の高圧造影剤インジェクター市場規模：製品別
- インジェクターシステムの市場規模
- 消耗品の市場規模
・世界の高圧造影剤インジェクター市場規模：用途別
- 心臓インターベンションの市場規模
- 放射線インターベンションの市場規模
- 血管内手術の市場規模
- 神経放射線インターベンションの市場規模
・世界の高圧造影剤インジェクター市場規模：エンドユーザー別
- 病院における市場規模
- 診断センターにおける市場規模
- 外来手術センターにおける市場規模
・世界の高圧造影剤インジェクター市場規模：地域別
- 北米の高圧造影剤インジェクター市場規模
アメリカの高圧造影剤インジェクター市場規模
カナダのの高圧造影剤インジェクター市場規模
…
- ヨーロッパの高圧造影剤インジェクター市場規模
イギリスの高圧造影剤インジェクター市場規模
ドイツの高圧造影剤インジェクター市場規模
フランスの高圧造影剤インジェクター市場規模
…
- アジア太平洋の高圧造影剤インジェクター市場規模
中国の高圧造影剤インジェクター市場規模
インドの高圧造影剤インジェクター市場規模
日本の高圧造影剤インジェクター市場規模
…
- 中南米の高圧造影剤インジェクター市場規模
ブラジルの高圧造影剤インジェクター市場規模
メキシコの高圧造影剤インジェクター市場規模
…
- その他地域の高圧造影剤インジェクター市場規模
・競争分析
・調査プロセス |
Global High Pressure Contrast Media Injectors Market is valued at approximately USD 134.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.1% over the forecast period 2022-2029. High Pressure Contrast Media Injectors are medical devices used during diagnostic imaging procedures such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and angiograms. These injectors are used to administer contrast media, which are substances that improve the visibility of internal body structures during imaging procedures. These injectors use a high-pressure injector system to deliver the contrast material through a catheter or needle into the patient’s body. This allows for more accurate and detailed imaging of the blood vessels and organs. These devices typically include a control panel, a syringe or cartridge filled with contrast media, and a power injector that pumps the contrast media into the patient at a controlled rate and pressure. The injection rate and volume can be adjusted based on the patient’s size and the specific imaging procedure being performed. The market demand is primarily driven by the factors such as combining modern technology with traditional high pressure contrast media injectors.
In addition, the rising incidence of chronic diseases is a key factor in the market’s expansion. The demand for high pressure contrast media injectors is expected to rise as the prevalence of chronic diseases like cancer, cardiovascular disease, and neurovascular disease rises. As per the data of the World Health Organization (WHO), Cancer is the largest cause of death in the world, accounting for over 10 million deaths in 2020, or roughly one in every six. Moreover, Cancer, cardiovascular disease, digestive problems, blood clots, and shattered bones have all grown considerably in recent years. This has increased the demand for numerous diagnostic solutions, including interventional radiology. Furthermore, the increasing investments towards healthcare Infrastructure, as well as rising research & development activities are presenting lucrative opportunities for market growth over the forthcoming years. However, the high cost of injectors is restricting the market growth over the forecast period of 2022-2029.
The key regions considered for the Global High Pressure Contrast Media Injectors Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rapid adoption of modern technologies and improved healthcare infrastructure, strong purchasing power, and a fair reimbursement environment are all advantages. Whereas, Asia Pacific is also expected to grow at the highest growth rate during the forecasting period. Factors such as Expanding healthcare spending, evolving healthcare infrastructure, and increased medical tourism in the region, as is the rising prevalence of chronic illnesses such as cancer, orthopedic ailments, epilepsy, and cardiovascular disease are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
Guerbet SA
Bracco S.P.A
Bayer AG
Medtron AG
NemotoKyorindo Co., Ltd.
Ulrich GmbH & Co. KG
Sino Medical-Device Technology Co. Ltd.
General electric Company
VIVID Imaging
Apollo RT Co. Ltd.
Recent Developments in the Market:
In February 2023, Bayer AG announced the acquisition of Blackford Analysis Ltd., a global strategic imaging AI platform and solutions supplier. As a result, Blackford, which has operations in the UK and the US, is now a completely owned subsidiary of Bayer AG. The company offers infrastructure as well as access to a diverse clinical application ecosystem centred on imaging and analytics. It maintains an arm’s length relationship in order to preserve its entrepreneurial culture as a critical foundation for generating successful innovation. Blackford will continue to expand its technology, channel partnerships, and ClinApp portfolio while benefiting from Bayer’s experience, infrastructure, and worldwide reach.
High Pressure Contrast Media Injectors Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Product, Application, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Single head injectors
Dual head injectors
Syringeless injectors
By Product:
Injector Systems
Consumables
By Application:
Interventional cardiology
Interventional radiology
Endovascular surgery
Interventional neuroradiology
By End-Use:
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. High Pressure Contrast Media Injectors Market, by Region, 2019-2029 (USD Million)
1.2.2. High Pressure Contrast Media Injectors Market, by Type, 2019-2029 (USD Million)
1.2.3. High Pressure Contrast Media Injectors Market, by Product, 2019-2029 (USD Million)
1.2.4. High Pressure Contrast Media Injectors Market, by Application, 2019-2029 (USD Million)
1.2.5. High Pressure Contrast Media Injectors Market, by End-Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global High Pressure Contrast Media Injectors Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global High Pressure Contrast Media Injectors Market Dynamics
3.1. High Pressure Contrast Media Injectors Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Combination of modern technology and traditional high pressure contrast media injectors.
3.1.1.2. Rise in prevalence of chronic diseases.
3.1.1.3. Increase in demand for diagnostic solutions.
3.1.2. Market Challenges
3.1.2.1. High cost associated with injectors.
3.1.3. Market Opportunities
3.1.3.1. Increasing investments towards the development of health infrastructure.
3.1.3.2. Rising research & development activities.
Chapter 4. Global High Pressure Contrast Media Injectors Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global High Pressure Contrast Media Injectors Market, by Type
6.1. Market Snapshot
6.2. Global High Pressure Contrast Media Injectors Market by Type, Performance – Potential Analysis
6.3. Global High Pressure Contrast Media Injectors Market Estimates & Forecasts by Type 2019-2029 (USD Million)
6.4. High Pressure Contrast Media Injectors Market, Sub Segment Analysis
6.4.1. Single head injectors
6.4.2. Dual head injectors
6.4.3. Syringeless injectors
Chapter 7. Global High Pressure Contrast Media Injectors Market, by Product
7.1. Market Snapshot
7.2. Global High Pressure Contrast Media Injectors Market by Product, Performance – Potential Analysis
7.3. Global High Pressure Contrast Media Injectors Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. High Pressure Contrast Media Injectors Market, Sub Segment Analysis
7.4.1. Injector System
7.4.2. Consumables
Chapter 8. Global High Pressure Contrast Media Injectors Market, by Application
8.1. Market Snapshot
8.2. Global High Pressure Contrast Media Injectors Market by Application, Performance – Potential Analysis
8.3. Global High Pressure Contrast Media Injectors Market Estimates & Forecasts by Application 2019-2029 (USD Million)
8.4. High Pressure Contrast Media Injectors Market, Sub Segment Analysis
8.4.1. Interventional cardiology
8.4.2. Interventional radiology
8.4.3. Endovascular surgery
8.4.4. Interventional neuroradiology
Chapter 9. Global High Pressure Contrast Media Injectors Market, by End-Use
9.1. Market Snapshot
9.2. Global High Pressure Contrast Media Injectors Market by End-Use, Performance – Potential Analysis
9.3. Global High Pressure Contrast Media Injectors Market Estimates & Forecasts by End-Use 2019-2029 (USD Million)
9.4. High Pressure Contrast Media Injectors Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Diagnostic Centers
9.4.3. Ambulatory Surgical Centers
Chapter 10. Global High Pressure Contrast Media Injectors Market, Regional Analysis
10.1. High Pressure Contrast Media Injectors Market, Regional Market Snapshot
10.2. North America High Pressure Contrast Media Injectors Market
10.2.1. U.S. High Pressure Contrast Media Injectors Market
10.2.1.1. Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Product breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-Use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada High Pressure Contrast Media Injectors Market
10.3. Europe High Pressure Contrast Media Injectors Market Snapshot
10.3.1. U.K. High Pressure Contrast Media Injectors Market
10.3.2. Germany High Pressure Contrast Media Injectors Market
10.3.3. France High Pressure Contrast Media Injectors Market
10.3.4. Spain High Pressure Contrast Media Injectors Market
10.3.5. Italy High Pressure Contrast Media Injectors Market
10.3.6. Rest of Europe High Pressure Contrast Media Injectors Market
10.4. Asia-Pacific High Pressure Contrast Media Injectors Market Snapshot
10.4.1. China High Pressure Contrast Media Injectors Market
10.4.2. India High Pressure Contrast Media Injectors Market
10.4.3. Japan High Pressure Contrast Media Injectors Market
10.4.4. Australia High Pressure Contrast Media Injectors Market
10.4.5. South Korea High Pressure Contrast Media Injectors Market
10.4.6. Rest of Asia Pacific High Pressure Contrast Media Injectors Market
10.5. Latin America High Pressure Contrast Media Injectors Market Snapshot
10.5.1. Brazil High Pressure Contrast Media Injectors Market
10.5.2. Mexico High Pressure Contrast Media Injectors Market
10.5.3. Rest of Latin America High Pressure Contrast Media Injectors Market
10.6. Rest of The World High Pressure Contrast Media Injectors Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Guerbet SA
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Bracco S.P.A
11.2.3. Bayer AG
11.2.4. Medtron AG
11.2.5. NemotoKyorindo Co., Ltd.
11.2.6. Ulrich GmbH & Co. KG
11.2.7. Sino Medical-Device Technology Co.
11.2.8. General electric Company
11.2.9. VIVID Imaging
11.2.10. Apollo RT Co. Ltd.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
